All lobbying filings

Tiber Creek Group

Tiber Creek Group filed a Q2 report for Astrazeneca on July 19, 2026, reporting $80,000 in lobbying income.

Lobbying for Astrazeneca

As filed: TIBER CREEK GROUP for ASTRAZENECA.

All filings by Tiber Creek Group · Everything Astrazeneca has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 19, 2026

Income

$80,000

What the client paid this registrant for the period.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

Issues related to the 340B Program - Public Health Service Act (PL 78-410).

Foreign Relations

Issues related to the Department of Defense, Uniform Formulary Beneficiary Advisory Panel.

Defense

Issues related to H.R. 9102 - Biotech Investment National Security Act of 2026 (BINSA).

Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform.

Bills named in this filing 1

H.R. 9102
BINSA Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.